Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 28,597	$ 25,434
General and administrative	16,106	14,904
Restructuring charges	0	5,107
Total operating expenses	44,703	45,445
Loss from operations	(44,703)	(45,445)
Other income (expense):
Interest income (expense), net	1,203	(229)
Loss on extinguishment of debt	942	0
Total other income (expense), net	261	(229)
Loss before income taxes	(44,442)	(45,674)
Income tax expense	43	30
Net loss	$ (44,485)	$ (45,704)
Net loss per share
Net loss per share, basic (in dollars per share)	$ (0.78)	$ (1.25)
Net loss per share, diluted (in dollars per share)	$ (0.78)	$ (1.25)
Weighted average common shares outstanding, basic (in shares)	57,275,454	36,522,716
Weighted average common shares outstanding, diluted (in shares)	57,275,454	36,522,716
Other comprehensive income:
Unrealized gain on marketable securities	$ 52	$ 170
Total other comprehensive income	52	170
Total comprehensive loss	$ (44,433)	$ (45,534)